Women on CagriSema lost 25% of their body weight in a post hoc trial analysis, while 79.6% of users had digestive side effects. The drug is not approved.
Women Lost 25% of Body Weight on CagriSema in Trial Analysis, but Most Users Had Digestive Side Effects
by | Oct 21, 2026 | Uncategorized | 0 comments
Recent Comments